(Q34099647)

31 July 2017

1 reference

title

Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine (English)

1 reference

ORCID Public Data File 2021

31 July 2017

main subject

regenerative medicine

1 reference

1 reference

1 reference

author name string

L Anastasia

1

1 reference

31 July 2017

G Pelissero

2

1 reference

31 July 2017

B Venerando

3

1 reference

31 July 2017

G Tettamanti

4

1 reference

31 July 2017

publication date

19 February 2010

1 reference

Cell Death & Differentiation

31 July 2017

published in

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

8

1 reference

31 July 2017

page(s)

1230-1237

1 reference

Induced pluripotent stem cells and reprogramming: seeing the science through the hype

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of human induced pluripotent stem cells from dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reprogramming of human somatic cells to pluripotency with defined factors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of germline-competent induced pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of pluripotent stem cells from adult mouse liver and stomach cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Variation in the safety of induced pluripotent stem cell lines

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

iPS cells and the politics of promise

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Developmental biology. Field leaps forward with new stem cell advances.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Human induced pluripotent stem cells free of vector and transgene sequences

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of induced pluripotent stem cells using recombinant proteins

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

A role for chemistry in stem cell biology

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

A fresh look at iPS cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Embryonic stem cells express neuronal properties in vitro

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

5-Azacytidine, a new, highly effective cancerostatic

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Can 5-azacytidine convert the adult stem cells into cardiomyocytes? A brief overview

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

A chemical approach to stem-cell biology and regenerative medicine

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Natural products as sources of new drugs over the last 25 years

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Sorafenib (BAY 43-9006): review of clinical development

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Amphibian limb regeneration: rebuilding a complex structure

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Nuclear reprogramming in cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Viable offspring derived from fetal and adult mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Cloning: pathways to a pluripotent future

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Nuclear reprogramming and pluripotency

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

https://api.crossref.org/works/10.1038%2FCDD.2010.14

1 reference

7 January 2021

Nuclei of embryonic stem cells reprogram somatic cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Changing potency by spontaneous fusion.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Mammalian myotube dedifferentiation induced by newt regeneration extract

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Molecular basis of transdifferentiation of pancreas to liver

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Dedifferentiation of lineage-committed cells by a small molecule

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Self-renewal of embryonic stem cells by a small molecule

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Myoseverin, a microtubule-binding molecule with novel cellular effects

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reversine increases the plasticity of lineage-committed cells toward neuroectodermal lineage

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Proteomic signature of reversine-treated murine fibroblasts by 2-D difference gel electrophoresis and MS: possible associations with cell signalling networks.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reversine increases the plasticity of lineage-committed mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Induction of growth arrest and polycomb gene expression by reversine allows C2C12 cells to be reprogrammed to various differentiated cell types.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Drug discovery and natural products: end of an era or an endless frontier?

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

The molecular mechanism of induced pluripotency: a two-stage switch

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Senescence impairs successful reprogramming to pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Suppression of induced pluripotent stem cell generation by the p53-p21 pathway

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

The Ink4/Arf locus is a barrier for iPS cell reprogramming

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of mouse induced pluripotent stem cells without viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

A combined chemical and genetic approach for the generation of induced pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Dissecting direct reprogramming through integrative genomic analysis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Generation of induced pluripotent stem cell lines from adult rat cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Rat embryonic stem-like (ES-like) cells can contribute to extraembryonic tissues in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Long-term culture and differentiation of rat embryonic stem cell-like cells into neuronal, glial, endothelial, and hepatic lineages

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Establishment of rat embryonic stem cells and making of chimera rats

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Capture of authentic embryonic stem cells from rat blastocysts

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

New cell lines from mouse epiblast share defining features with human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Directed differentiation of embryonic stem cells into motor neurons

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Small molecules that induce cardiomyogenesis in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Mesenchymal progenitor cell research: limitations and recommendations

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Regeneration of the central nervous system using endogenous repair mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Regenerating the heart

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Regenerative medicine and stem cell based drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Cardiogenic small molecules that enhance myocardial repair by stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2010.14

7 January 2021

Identifiers

DOI

10.1038/CDD.2010.14

1 reference

31 July 2017

1 reference